🔎 Trials Near Me

Home › Neurologic Diseases

Neurologic Diseases clinical trials recruiting in the U.S.

60 studies for Neurologic Diseases are recruiting participants at sites across the United States.

Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.

Cities with the most studies

By state

Recently updated studies

Evaluation and Treatment of Neurosurgical Disorders

RecruitingObservational study
Ages 4 to 99 · All sexes · Updated Sep 29, 2026 · NCT00060541

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

RecruitingObservational studyHealthy volunteers welcome
6 Weeks · All sexes · Updated Sep 29, 2026 · NCT00271622

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

RecruitingPhase 1/2
6 Months · All sexes · Updated Sep 24, 2026 · NCT05757141

NightWare and Cardiovascular Health in Veterans With PTSD

RecruitingHealthy volunteers welcome
Ages 22 to 88 · All sexes · Updated Sep 22, 2026 · NCT06419959

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

Product Surveillance Registry

RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07098806

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

RecruitingObservational study
7 Months – 15 Months · All sexes · Updated Aug 31, 2026 · NCT06805695

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Recruiting
Ages 50 and older · All sexes · Updated Aug 27, 2026 · NCT06993142

Top-Down Attentional Control of Visual-Processing

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Aug 24, 2026 · NCT01087281

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

RecruitingObservational studyHealthy volunteers welcome
30 Days – 99 Years · All sexes · Updated Aug 24, 2026 · NCT01778504

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Recruiting
Ages 3 to 21 · All sexes · Updated Aug 19, 2026 · NCT05527652

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Recruiting
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07218133

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

Recruiting
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07759115

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

RecruitingPhase 3
24 Hours – 7 Months · Men · Updated Aug 12, 2026 · NCT06255782

Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology

RecruitingObservational study
Ages 3 to 99 · All sexes · Updated Aug 7, 2026 · NCT06203626

Ask Questions About Clinical Trials

Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07343297

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.